نتایج جستجو برای: tak

تعداد نتایج: 2900  

Journal: :International journal of clinical and experimental medicine 2015
Yang Zhao Yan Xin Jie Gao Ru-Yang Teng Hai-Chen Chu

BACKGROUND The current study investigated the analgesic effect of the Toll-like receptor 4 (TLR4) specific antagonist TAK-242 on neuropathic pain in rats and its underlying mechanism. METHODS A total of 132 adult Sprague-Dawley (SD) rats were randomly divided into four groups: the sham operation group, the neuropathic pain model group, the TAK-242 low-dose treatment group, and the TAK-242 hig...

Journal: :The Journal of pharmacology and experimental therapeutics 2012
Hiroaki Yashiro Yoshiyuki Tsujihata Koji Takeuchi Masatoshi Hazama Paul R V Johnson Patrik Rorsman

G protein-coupled receptor 40 (GPR40)/free fatty acid 1 (FFA1) is a G protein-coupled receptor involved in free fatty acid-induced insulin secretion. To analyze the effect of our novel GPR40/FFA1-selective agonist, [(3S)-6-({2',6'-dimethyl-4'-[3-(methylsulfonyl)propoxy]biphenyl-3-yl}methoxy)-2,3-dihydro-1-benzofuran-3-yl]acetic acid hemi-hydrate (TAK-875), on insulin and glucagon secretion, we ...

2018
Yoshikazu Nakaoka Mitsuaki Isobe Syuji Takei Yoshiya Tanaka Tomonori Ishii Shumpei Yokota Akira Nomura Seitaro Yoshida Norihiro Nishimoto

OBJECTIVE To investigate the efficacy and safety of the interleukin-6 receptor antibody tocilizumab in patients with Takayasu arteritis (TAK). METHODS Patients with TAK who had relapsed within the previous 12 weeks were induced into remission with oral glucocorticoid therapy. In this double-blind, placebo-controlled trial, patients were randomly assigned 1:1 to receive weekly tocilizumab 162 ...

2017
Toshiki Nakajima Hajime Yoshifuji Masakazu Shimizu Koji Kitagori Kosaku Murakami Ran Nakashima Yoshitaka Imura Masao Tanaka Koichiro Ohmura Fumihiko Matsuda Chikashi Terao Tsuneyo Mimori

BACKGROUND A previous study revealed the association between susceptibility to Takayasu arteritis (TAK) and a single nucleotide polymorphism (SNP) rs6871626 located in IL12B, which encodes interleukin (IL)-12p40, a common component of IL-12p70 and IL-23. We investigated the expression of these cytokines in patients with TAK, stratifying them into those with or without the risk allele at the rs6...

2012
Sophie E. Hussey Hanyu Liang Sheila R. Costford Amira Klip Ralph A. DeFronzo Alicia Sanchez-Avila Brian Ely Nicolas Musi

Emerging evidence suggests that TLR (Toll-like receptor) 4 and downstream pathways [MAPKs (mitogen-activated protein kinases) and NF-κB (nuclear factor κB)] play an important role in the pathogenesis of insulin resistance. LPS (lipopolysaccharide) and saturated NEFA (non-esterified fatty acids) activate TLR4, and plasma concentrations of these TLR4 ligands are elevated in obesity and Type 2 dia...

Journal: :J. Applied Mathematics 2012
Jukkrit Kluabwang Deacha Puangdownreong Sarawut Sujitjorn

1 Control and Automation Research Unit, Power Electronics, Machines, and Control Research Group, School of Electrical Engineering, Suranaree University of Technology, Nakhon Ratchasima 30000, Thailand 2 Department of Electrical Engineering, Rajamangala University of Technology Lanna Tak, Tak 63000, Thailand 3 Department of Electrical Engineering, South-East Asia University, Bangkok 10160, Thailand

Journal: :Debate Feminista 2012

2016
Nobutaka Suzuki Tatsuo Ito Hisanori Matsui Masayuki Takizawa

TAK-475 (lapaquistat acetate) and its active metabolite-I (TAK-475 M-I) inhibit squalene synthase, which catalyzes the conversion of farnesyl diphosphate (FPP) to squalene. FPP is a substrate for synthesis of other mevalonate-derived isoprenoids (MDIs) such as farnesol (FOH), geranlygeranyl diphosphate (GGPP), and geranylgeraniol. In patients with MKD, a rare autosomal recessive disorder, defec...

Journal: :Clinical cancer research : an official journal of the American Association for Cancer Research 2015
Jonathan Goldman S Gail Eckhardt Mitesh J Borad Kelly K Curtis Manuel Hidalgo Emiliano Calvo David P Ryan Lori J Wirth Asit Parikh James Partyka Helene Faessel Esha Gangolli Sally Stewart Lee S Rosen Daniel W Bowles

PURPOSE This first-in-human study assessed safety, tolerability, pharmacokinetics, pharmacodynamics, and preliminary clinical activity of single and multiple doses of TAK-441, an investigational inhibitor of the Hedgehog signaling pathway. EXPERIMENTAL DESIGN Patients with advanced, solid tumors received daily oral TAK-441 (50-1,600 mg/day); daily dose was doubled in each subsequent cohort un...

Journal: :Klinisk Sygepleje 2016

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید